In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.

[EX Q]: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Office of Strategic Services 
Congressional Gold Medal Act''.

SEC. 2. FINDINGS.

    The Congress finds the following:
            (1) The Office of Strategic Services (OSS) was America's 
        first effort to implement a system of strategic intelligence 
        during World War II and provided the basis for the modern-day 
        American intelligence and special operations communities. The 
        U.S. Special Operations Command and the National Clandestine 
        Service chose the OSS spearhead as their insignias.
            (2) OSS founder General William J. Donovan is the only 
        person in American history to receive our Nation's four highest 
        decorations, including the Medal of Honor. Upon learning of his 
        death in 1959, President Eisenhower called General Donovan the 
        ``last hero''. In addition to founding and leading the OSS, 
        General Donovan was also selected by President Roosevelt, who 
        called him his ``secret legs'', as an emissary to Great Britain 
        and continental Europe before the United States entered World 
        War II.
            (3) All the military branches during World War II 
        contributed personnel to the OSS. The present-day Special 
        Operations Forces trace their lineage to the OSS. Its Maritime 
        Unit was a precursor to the U.S. Navy SEALs. The OSS 
        Operational Groups and Jedburghs were forerunners to U.S. Army 
        Special Forces. The 801st/492nd Bombardment Group 
        (``Carpetbaggers'') were progenitors to the Air Force Special 
        Operations Command. The Marines who served in the OSS, 
        including the actor Sterling Hayden (a Silver Star recipient), 
        Col. William Eddy (a Distinguished Service Cross recipient who 
        was described as the ``nearest thing the United States has had 
        to a Lawrence of Arabia''), and Col. Peter Ortiz (a two-time 
        Navy Cross recipient), were predecessors to the Marine Special 
        Operations Command. U.S. Coast Guard personnel were recruited 
        for the Maritime Unit and its Operational Swimmer Group.
            (4) The OSS organized, trained, supplied, and fought with 
        resistance organizations throughout Europe and Asia that played 
        an important role in America's victory during World War II. 
        General Eisenhower credited the OSS's covert contribution in 
        France to the equivalent to having an extra military division. 
        General Eisenhower told General Donovan that if it did nothing 
        else, the photographic reconnaissance conducted by the OSS 
        prior to the D-Day Invasion justified its creation.
            (5) Four future directors of central intelligence served as 
        OSS officers: William Casey, William Colby, Allen Dulles, and 
        Richard Helms.
            (6) Women comprised more than one-third of OSS personnel 
        and played a critical role in the organization. They included 
        Virginia Hall, the only civilian female to receive a 
        Distinguished Service Cross in World War II, and Julia Child.
            (7) OSS recruited Fritz Kolbe, a German diplomat who became 
        America's most important spy against the Nazis in World War II.
            (8) America's leading scientists and scholars served in the 
        OSS Research and Analysis Branch, including Ralph Bunche, the 
        first African-American to receive the Nobel Peace Prize; 
        Pulitzer Prize-winning historian Arthur Schlesinger, Jr.; 
        Supreme Court Justice Arthur Goldberg; Sherman Kent; John King 
        Fairbank; and Walt Rostow. Its ranks included seven future 
        presidents of the American Historical Association, five of the 
        American Economic Association, and two Nobel laureates.
            (9) The U.S. Department of State's Bureau of Intelligence 
        and Research traces its creation to the OSS Research and 
        Analysis Branch.
            (10) James Donovan, who was portrayed by Tom Hanks in the 
        Steven Spielberg movie ``Bridge of Spies'' and negotiated the 
        release of U-2 pilot Francis Gary Powers, served as General 
        Counsel of the OSS.
            (11) The OSS invented and employed new technology through 
        its Research and Development Branch, inventing new weapons and 
        revolutionary communications equipment. Dr. Christian 
        Lambertsen invented the first underwater rebreathing apparatus 
        that was first utilized by the OSS and is known today as SCUBA.
            (12) OSS Detachment 101 operated in Burma and pioneered the 
        art of unconventional warfare. It was the first United States 
        unit to deploy a large guerrilla army deep in enemy territory. 
        It has been credited with the highest kill/loss ratio for any 
        infantry-type unit in American military history and was awarded 
        a Presidential Unit Citation.
            (13) Its X-2 branch pioneered counterintelligence with the 
        British and established the modern counterintelligence 
        community. The network of contacts built by the OSS with 
        foreign intelligence services led to enduring Cold War 
        alliances.
            (14) Operation Torch, the Allied invasion of French North 
        Africa in November 1942, was aided by the networks established 
        and information acquired by the OSS to guide Allied landings.
            (15) OSS Operation Halyard rescued more than 500 downed 
        airmen trapped behind enemy lines in Yugoslavia, one of the 
        most daring and successful rescue operations of World War II.
            (16) OSS ``Mercy Missions'' at the end of World War II 
        saved the lives of thousands of Allied prisoners of war whom it 
        was feared would be murdered by the Japanese.
            (17) The handful of surviving men and women of the OSS whom 
        General Donovan said performed ``some of the bravest acts of 
        the war'' are members of the ``Greatest Generation''. They have 
        never been collectively recognized for their heroic and 
        pioneering service in World War II.

SEC. 3. CONGRESSIONAL GOLD MEDAL.

    (a) Presentation Authorized.--The Speaker of the House of 
Representatives and the President pro tempore of the Senate shall make 
appropriate arrangements for the presentation, on behalf of the 
Congress, of a gold medal of appropriate design in commemoration to the 
members of the Office of Strategic Services (OSS), in recognition of 
their superior service and major contributions during World War II.
    (b) Design and Striking.--For purposes of the presentation referred 
to in subsection (a), the Secretary of the Treasury (referred to in 
this Act as the ``Secretary'') shall strike a gold medal with suitable 
emblems, devices, and inscriptions, to be determined by the Secretary.
    (c) Smithsonian Institution.--
            (1) In general.--Following the award of the gold medal in 
        commemoration to the members of the Office of Strategic 
        Services under subsection (a), the gold medal shall be given to 
        the Smithsonian Institution, where it will be displayed as 
        appropriate and made available for research.
            (2) Sense of congress.--It is the sense of Congress that 
        the Smithsonian Institution should make the gold medal received 
        under paragraph (1) available for display elsewhere, 
        particularly at other appropriate locations associated with the 
        Office of Strategic Services.

SEC. 4. DUPLICATE MEDALS.

    The Secretary may strike and sell duplicates in bronze of the gold 
medal struck pursuant to section 3 under such regulations as the 
Secretary may prescribe, at a price sufficient to cover the cost 
thereof, including labor, materials, dies, use of machinery, and 
overhead expenses, and the cost of the gold medal.

SEC. 5. STATUS OF MEDALS.

    (a) National Medals.--The medals struck pursuant to this Act are 
national medals for purposes of chapter 51 of title 31, United States 
Code.
    (b) Numismatic Items.--For purposes of section 5134 of title 31, 
United States Code, all medals struck under this Act shall be 
considered to be numismatic items.
[EX A]: Office of Strategic Services Congressional Gold Medal Act  This bill requires the Speaker of the House of Representatives and the President pro tempore of the Senate to arrange for the presentation of a Congressional Gold Medal to the members of the Office of Strategic Services in recognition of their service and contributions during World War II.

[EX Q]: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Drug Competition Act of 2002''.

SEC. 2. FINDINGS.

    Congress finds that--
            (1) prescription drug prices are increasing at an alarming 
        rate and are a major worry of many senior citizens and American 
        families;
            (2) there is a potential for companies with patent rights 
        regarding brand name drugs and companies which could 
        manufacture generic versions of such drugs to enter into 
        financial deals that could tend to restrain trade and greatly 
        reduce competition and increase prescription drug expenditures 
        for American citizens; and
            (3) enhancing competition among these companies can 
        significantly reduce prescription drug expenditures for 
        Americans.

SEC. 3. PURPOSES.

    The purposes of this Act are--
            (1) to provide timely notice to the Department of Justice 
        and the Federal Trade Commission regarding agreements between 
        companies with patent rights regarding brand name drugs and 
        companies which could manufacture generic versions of such 
        drugs; and
            (2) by providing timely notice, to enhance the 
        effectiveness and efficiency of the enforcement of the 
        antitrust and competition laws of the United States.

SEC. 4. DEFINITIONS.

    In this Act:
            (1) ANDA.--The term ``ANDA'' means an Abbreviated New Drug 
        Application, as defined under section 201(aa) of the Federal 
        Food, Drug, and Cosmetic Act (21 U.S.C. 321(aa)).
            (2) Assistant attorney general.--The term ``Assistant 
        Attorney General'' means the Assistant Attorney General in 
        charge of the Antitrust Division of the Department of Justice.
            (3) Brand name drug.--The term ``brand name drug'' means a 
        drug approved under section 505(c) of the Federal Food, Drug, 
        and Cosmetic Act (21 U.S.C. 355(c)).
            (4) Brand name drug company.--The term ``brand name drug 
        company'' means the party that received Food and Drug 
        Administration approval to market a brand name drug pursuant to 
        an NDA, where that drug is the subject of an ANDA, or a party 
        owning or controlling enforcement of any patent listed in the 
        Approved Drug Products With Therapeutic Equivalence Evaluations 
        of the Food and Drug Administration for that drug, under 
        section 505(b) of the Federal Food, Drug, and Cosmetic Act (21 
        U.S.C. 355(b)).
            (5) Commission.--The term ``Commission'' means the Federal 
        Trade Commission.
            (6) Generic drug.--The term ``generic drug'' means a 
        product that the Food and Drug Administration has approved 
        under section 505(j) of the Federal Food, Drug, and Cosmetic 
        Act (21 U.S.C. 355(j)).
            (7) Generic drug applicant.--The term ``generic drug 
        applicant'' means a person who has filed or received approval 
        for an ANDA under section 505(j) of the Federal Food, Drug, and 
        Cosmetic Act (21 U.S.C. 355(j)).
            (8) NDA.--The term ``NDA'' means a New Drug Application, as 
        defined under section 505(b) et seq. of the Federal Food, Drug, 
        and Cosmetic Act (21 U.S.C. 355(b) et seq.)

SEC. 5. NOTIFICATION OF AGREEMENTS.

    (a) In General.--
            (1) Requirement.--A generic drug applicant that has 
        submitted an ANDA containing a certification under section 
        505(j)(2)(vii)(IV) of the Federal Food, Drug, and Cosmetic Act 
        (21 U.S.C. 355(j)(2)(vii)(IV)) and a brand name drug company 
        that enter into an agreement described in paragraph (2), prior 
        to the generic drug that is the subject of the application 
        entering the market, shall each file the agreement as required 
        by subsection (b).
            (2) Definition.--An agreement described in this paragraph 
        is an agreement regarding--
                    (A) the manufacture, marketing or sale of the brand 
                name drug that is the subject of the generic drug 
                applicant's ANDA;
                    (B) the manufacture, marketing or sale of the 
                generic drug that is the subject of the generic drug 
                applicant's ANDA; or
                    (C) the 180-day period referred to in section 
                505(j)(5)(B)(iv) of the Federal Food, Drug, and 
                Cosmetic Act (21 U.S.C. 355(j)(5)(B)(iv)) as it applies 
                to such ANDA or to any other ANDA based on the same 
                brand name drug.
    (b) Filing.--
            (1) Agreement.--The generic drug applicant and the brand 
        name drug company entering into an agreement described in 
        subsection (a)(2) shall file with the Assistant Attorney 
        General and the Commission the text of any such agreement, 
        except that the generic drug applicant and the brand-name drug 
        company shall not be required to file an agreement that solely 
        concerns--
                    (A) purchase orders for raw material supplies;
                    (B) equipment and facility contracts;
                    (C) employment or consulting contracts; or
                    (D) packaging and labeling contracts.
            (2) Other agreements.--The generic drug applicant and the 
        brand name drug company entering into an agreement described in 
        subsection (a)(2) shall file with the Assistant Attorney 
        General and the Commission the text of any other agreements not 
        described in subsection (a)(2) between the generic drug 
        applicant and the brand name drug company which are contingent 
        upon, provide a contingent condition for, or are otherwise 
        related to an agreement which must be filed under this Act.
            (3) Description.--In the event that any agreement required 
        to be filed by paragraph (1) or (2) has not been reduced to 
        text, both the generic drug applicant and the brand name drug 
        company shall file written descriptions of the non-textual 
        agreement or agreements that must be filed sufficient to reveal 
        all of the terms of the agreement or agreements.

SEC. 6. FILING DEADLINES.

    Any filing required under section 5 shall be filed with the 
Assistant Attorney General and the Commission not later than 10 
business days after the date the agreements are executed.

SEC. 7. DISCLOSURE EXEMPTION.

    Any information or documentary material filed with the Assistant 
Attorney General or the Commission pursuant to this Act shall be exempt 
from disclosure under section 552 of title 5, and no such information 
or documentary material may be made public, except as may be relevant 
to any administrative or judicial action or proceeding. Nothing in this 
section is intended to prevent disclosure to either body of Congress or 
to any duly authorized committee or subcommittee of the Congress.

SEC. 8. ENFORCEMENT.

    (a) Civil Penalty.--Any brand name drug company or generic drug 
applicant which fails to comply with any provision of this Act shall be 
liable for a civil penalty of not more than $11,000, for each day 
during which such entity is in violation of this Act. Such penalty may 
be recovered in a civil action brought by the United States, or brought 
by the Commission in accordance with the procedures established in 
section 16(a)(1) of the Federal Trade Commission Act (15 U.S.C. 56(a)).
    (b) Compliance and Equitable Relief.--If any brand name drug 
company or generic drug applicant fails to comply with any provision of 
this Act, the United States district court may order compliance, and 
may grant such other equitable relief as the court in its discretion 
determines necessary or appropriate, upon application of the Assistant 
Attorney General or the Commission.

SEC. 9. RULEMAKING.

    The Commission, with the concurrence of the Assistant Attorney 
General and by rule in accordance with section 553 of title 5 United 
States Code, consistent with the purposes of this Act--
            (1) may define the terms used in this Act;
            (2) may exempt classes of persons or agreements from the 
        requirements of this Act; and
            (3) may prescribe such other rules as may be necessary and 
        appropriate to carry out the purposes of this Act.

SEC. 10. SAVINGS CLAUSE.

    Any action taken by the Assistant Attorney General or the 
Commission, or any failure of the Assistant Attorney General or the 
Commission to take action, under this Act shall not bar any proceeding 
or any action with respect to any agreement between a brand name drug 
company and a generic drug applicant at any time under any other 
provision of law, nor shall any filing under this Act constitute or 
create a presumption of any violation of any antitrust or competition 
laws.

SEC. 11. EFFECTIVE DATE.

    This Act shall--
            (1) take effect 30 days after the date of enactment of this 
        Act; and
            (2) shall apply to agreements described in section 5 that 
        are entered into 30 days after the date of enactment of this 
        Act.

            Passed the Senate November 18, 2002.

            Attest:

                                                  JERI THOMSON,

                                                             Secretary.
[EX A]: Drug Competition Act of 2002 - (Sec. 5) Requires a generic drug applicant that has submitted an Abbreviated New Drug Application (ANDA) and a brand name drug company that enter into an agreement, prior to the generic drug entering the market, regarding the manufacture, marketing, or sale of the brand name or the generic drug, or regarding the 180-day semi-exclusivity period referred to in the Federal Food, Drug, and Cosmetic Act as it applies to such ANDA or any other ANDA based on the same brand name drug, to each file such agreement and any related agreements with the Assistant Attorney General and the Federal Trade Commission (FTC). Makes an exception for agreements that solely concern purchase orders for raw material supplies, equipment and facility contracts, or employment or consulting contracts. Requires such agreements to be filed not later than ten business days after the date they are executed.(Sec. 7) Exempts any such information or documentary material filed from disclosure under the Freedom of Information Act. Prohibits such information or material from being made public, except as relevant to any administrative or judicial action or proceeding.(Sec. 8) Subjects an applicant or company to a civil penalty of up to $11,000 for each day such entity fails to comply with this Act, recoverable in a civil action brought by the United States or the FTC. Authorizes a U.S. district court to order compliance and grant equitable relief.

[EX Q]: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Alexis Agin Identity Theft 
Protection Act of 2013''.

SEC. 2. LIMITATION ON DISTRIBUTION OF DEATH INFORMATION FURNISHED TO OR 
              MAINTAINED BY THE SOCIAL SECURITY ADMINISTRATION.

    (a) In General.--Section 205(r) of the Social Security Act (42 
U.S.C. 405(r)) is amended--
            (1) in paragraph (2), by inserting ``, and to ensure 
        completeness, timeliness, and accuracy of,'' after 
        ``transmitting'';
            (2) by striking paragraph (3) and inserting the following:
    ``(3) The Commissioner of Social Security shall, to the extent 
feasible, provide for the use of information regarding deceased 
individuals furnished to or maintained by the Commissioner, subject to 
such safeguards as the Commissioner of Social Security determines are 
necessary or appropriate to protect the information from unauthorized 
use or disclosure, to any Federal or State agency providing or 
administering Federally funded benefits to individuals, other than 
benefits under this Act, through a cooperative arrangement with such 
agency designed to ensure proper payment of those benefits with respect 
to such individuals if--
            ``(A) under such arrangement the agency provides 
        reimbursement to the Commissioner of Social Security for the 
        reasonable costs of carrying out such arrangement, including 
        the reasonable costs associated with the collection and 
        maintenance of information regarding deceased individuals 
        furnished to the Commissioner pursuant to paragraph (1); and
            ``(B) such arrangement does not conflict with the duties of 
        the Commissioner of Social Security under paragraph (1).'';
            (3) in paragraph (4), by inserting ``or in benefit and 
        pension plans for employees of the States or local 
        governments'' after ``by the States'';
            (4) by striking paragraph (5) and inserting the following:
    ``(5)(A) The Commissioner of Social Security may use or provide for 
the use of information regarding deceased individuals furnished to or 
maintained by the Commissioner, subject to such safeguards as the 
Commissioner of Social Security determines are necessary or appropriate 
to protect the information from unauthorized use or disclosure, 
provided the requirements of subparagraphs (A) and (B) of paragraph (3) 
are met and such information is provided--
            ``(i) to any Federal agency through a cooperative agreement 
        with such agency for the purpose of law enforcement or tax 
        administration; or
            ``(ii) for statistical and research activities conducted by 
        Federal and State agencies.
    ``(B) A Federal or State agency may disclose death information 
obtained from the Commissioner to a contractor for the purposes of 
assisting with such law enforcement, tax administration, or statistical 
and research activities, provided that the agency ensures, at a 
minimum, that the contractor fulfills the requirements of clauses (ii) 
and (iv) of paragraph (7)(E).'';
            (5) by striking paragraph (7) and inserting the following:
    ``(7)(A) For purposes of this paragraph, death information shall 
consist of information regarding deceased individuals maintained by the 
Commissioner of Social Security, except for information furnished to or 
maintained by the Commissioner pursuant to paragraphs (1) or (2), and 
the death information to be provided shall consist only of the name, 
social security number, date of birth, and date of death of a deceased 
individual.''
    ``(B) The Commissioner may disclose death information under this 
paragraph to the Secretary of Defense provided that--
            ``(i) the Secretary uses the information provided solely 
        for the purpose of assisting in the identification of 
        unidentified remains, and
            ``(ii) the Secretary enforces requirements similar to those 
        in clauses (i), (ii), (iv), (v), (vi), and (vii) with respect 
        to any contractor the Secretary hires to assist in such 
        identifications.
    ``(C) The Commissioner of Social Security may disclose death 
information, except for information furnished to or maintained by the 
Commissioner of Social Security pursuant to paragraphs (1) or (2), 
provided the requirements of this paragraph and the requirements of 
subparagraphs (A) and (B) of paragraph (3) are met.
    ``(D) The Commissioner may disclose--
            ``(i) to any entity, information maintained by the 
        Commissioner concerning individuals whose date of death 
        occurred at least 3 calendar years prior to the year that the 
        entity requests such information pursuant to a written 
        agreement; and
            ``(ii) to any entity `certified' by the Commissioner under 
        subparagraph (E), information maintained by the Commissioner 
        concerning individuals whose date of death does not satisfy the 
        requirements of clause (i), pursuant to a written agreement 
        between the Commissioner and the entity.
    ``(E) For purposes of this paragraph an entity is `certified' only 
if the Commissioner--
            ``(i) establishes procedures to certify and decertify 
        entities eligible to obtain such information;
            ``(ii) includes in the agreement with such an entity 
        provisions to require such entity to safeguard the information 
        provided, assure that the information is used only for the 
        purpose which was the basis for the certification, assure that 
        the information is not disclosed by the entity to any other 
        entity, and include contractual penalties, including monetary 
        penalties and loss of certification, for the violation of any 
        requirements imposed by the Commissioner as a condition of 
        receiving the information;
            ``(iii) requires that the entity demonstrate that--
                    ``(I) it has a legitimate business need for the 
                information, which shall include a requirement that the 
                information regarding a deceased individual will aid in 
                preventing financial harm to the entity or to a 
                customer or client of the entity or will aid in 
                permitting the entity to fulfill an obligation to a 
                beneficiary of an individual that is contingent upon 
                the death of such individual; or
                    ``(II) it has a legitimate interest in preventing 
                fraud or unauthorized financial transactions;
            ``(iv) requires that the entity demonstrate that it has 
        infrastructure and procedures in place to prevent wrongful 
        access to or the disclosure of information provided by the 
        Commissioner;
            ``(v) determines that the entity has adequate experience 
        and expertise in maintaining the confidentiality and security 
        of information;
            ``(vi) includes such other requirements and restrictions as 
        the Commissioner deems appropriate to assure the 
        confidentiality of the information; and
            ``(vii) requires that the entity permit periodic and 
        unscheduled audits of the entity to assure compliance with the 
        requirements established by the Commissioner.
    ``(F) The Commissioner shall establish application and other fees 
to be paid by entities seeking to be certified or to maintain 
certification under this paragraph so that the Commissioner is fully 
reimbursed for all costs associated with development of the 
certification process, evaluating applications, auditing compliance 
with the requirements established by the Commissioner, inspecting 
records and assuring compliance with contract requirements, and any 
other costs associated with assuring continuing eligibility for 
certification under this paragraph.
    ``(G) For purposes of this paragraph, the terms `entity' or 
`entities' includes `individual' and `individuals' respectively.
    ``(H) The Commissioner may delegate any of the activities under 
this paragraph to another agency and may perform any activity through a 
contractor, provided that the delegation or contract requires such 
agency or contractor to comply with all requirements of this section 
and of the implementing policies developed by the Commissioner.'';
            (6) by adding at the end the following new paragraph:
    ``(10) Information related to a deceased individual received by the 
Commissioner of Social Security other than as described in paragraph 
(1) shall be treated for purposes of paragraph (6) in the same manner 
as information received as described in paragraph (1).''.
    (b) Report.--Not later than 1 year after the date of the enactment 
of this Act and each year thereafter through 2019, the Commissioner of 
Social Security shall submit to the Committee on Finance of the Senate 
and the Committee on Ways and Means of the House of Representatives a 
report describing the entities certified by the Commissioner under 
section 205(r)(7) of the Social Security Act (42 U.S.C. 405(r)(7)) 
during the preceding year and their compliance with the requirements of 
subparagraph (E) of such section.
    (c) Effective Dates.--
            (1) In general.--Except as provided in paragraph (2), the 
        amendments made by this section take effect on the date that is 
        60 days after the date of the enactment of this Act.
            (2) Exception.--The amendment made by subsection (a)(6) 
        shall take effect on January 1, 2014.
    (d) Sunset.--Subparagraphs (C) through (H) of section 205(r)(7) of 
the Social Security Act (42 U.S.C. 405(r)(7)) (as amended by subsection 
(a)) shall cease to be effective on January 1, 2019, except that--
            (1) clauses (ii) and (iv) of subparagraph (E) of such 
        section shall continue to apply for purposes of section 
        205(r)(5)(B) of such Act (42 U.S.C. 405(r)(5)(B)) (as amended 
        by subsection (a)).
[EX A]:
Alexis Agin Identity Theft Protection Act of 2013 - Amends title II (Old Age, Survivors and Disability Insurance) (OASDI) of the Social Security Act to revise the treatment of death information furnished to or maintained by the Social Security Administration (SSA). Authorizes the Commissioner of Social Security to use or provide such information to federal and state agencies for statistical and research activities or to any federal agency for law enforcement or tax administration purposes. Authorizes disclosure of such information by: (1) federal and state agencies to contractors to assist with similar activities, (2) the Commissioner to entities concerning certain individuals who died more than three years earlier as well as to entities certified by the Commissioner, and (3) the Commissioner to the Secretary of Defense (DOD) to assist in the identification of remains.